ABOVE FOOD INGREDIENTS INC (ABVE) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:ABVE • CA00373V1004

1.96 USD
-0.07 (-3.45%)
At close: Feb 5, 2026
2.03 USD
+0.07 (+3.57%)
After Hours: 2/5/2026, 4:20:16 PM
Fundamental Rating

1

Taking everything into account, ABVE scores 1 out of 10 in our fundamental rating. ABVE was compared to 87 industry peers in the Food Products industry. ABVE has a bad profitability rating. Also its financial health evaluation is rather negative. ABVE is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • ABVE had negative earnings in the past year.
  • ABVE had a positive operating cash flow in the past year.
  • ABVE had negative earnings in each of the past 5 years.
  • ABVE had negative operating cash flow in 4 of the past 5 years.
ABVE Yearly Net Income VS EBIT VS OCF VS FCFABVE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 -20M -40M

1.2 Ratios

  • ABVE has a worse Return On Assets (-107.17%) than 90.80% of its industry peers.
Industry RankSector Rank
ROA -107.17%
ROE N/A
ROIC N/A
ROA(3y)-21.86%
ROA(5y)-13.11%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ABVE Yearly ROA, ROE, ROICABVE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -500 -1K -1.5K

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for ABVE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ABVE Yearly Profit, Operating, Gross MarginsABVE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -5 -10

1

2. Health

2.1 Basic Checks

  • ABVE does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, ABVE has about the same amount of shares outstanding.
  • ABVE has a worse debt/assets ratio than last year.
ABVE Yearly Shares OutstandingABVE Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
ABVE Yearly Total Debt VS Total AssetsABVE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

  • ABVE has an Altman-Z score of 1.26. This is a bad value and indicates that ABVE is not financially healthy and even has some risk of bankruptcy.
  • ABVE has a worse Altman-Z score (1.26) than 65.52% of its industry peers.
  • The Debt to FCF ratio of ABVE is 21.93, which is on the high side as it means it would take ABVE, 21.93 years of fcf income to pay off all of its debts.
  • ABVE has a Debt to FCF ratio (21.93) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 21.93
Altman-Z 1.26
ROIC/WACCN/A
WACC7.09%
ABVE Yearly LT Debt VS Equity VS FCFABVE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 20M -20M -40M

2.3 Liquidity

  • A Current Ratio of 0.23 indicates that ABVE may have some problems paying its short term obligations.
  • The Current ratio of ABVE (0.23) is worse than 94.25% of its industry peers.
  • ABVE has a Quick Ratio of 0.23. This is a bad value and indicates that ABVE is not financially healthy enough and could expect problems in meeting its short term obligations.
  • ABVE's Quick ratio of 0.18 is on the low side compared to the rest of the industry. ABVE is outperformed by 94.25% of its industry peers.
Industry RankSector Rank
Current Ratio 0.23
Quick Ratio 0.18
ABVE Yearly Current Assets VS Current LiabilitesABVE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 50M 100M 150M

1

3. Growth

3.1 Past

  • The earnings per share for ABVE have decreased strongly by -145.55% in the last year.
  • Looking at the last year, ABVE shows a very strong growth in Revenue. The Revenue has grown by 84.68%.
EPS 1Y (TTM)-145.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2053%
Revenue 1Y (TTM)84.68%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ABVE Yearly Revenue VS EstimatesABVE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 100M 200M 300M

1

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ABVE. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ABVE Price Earnings VS Forward Price EarningsABVE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of ABVE is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 32.1
EV/EBITDA N/A
ABVE Per share dataABVE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • ABVE does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

ABOVE FOOD INGREDIENTS INC

NASDAQ:ABVE (2/5/2026, 4:20:16 PM)

After market: 2.03 +0.07 (+3.57%)

1.96

-0.07 (-3.45%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)11-18
Earnings (Next)N/A
Inst Owners12.92%
Inst Owner Change33.18%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap100.33M
Revenue(TTM)732.19M
Net Income(TTM)-120.40M
AnalystsN/A
Price TargetN/A
Short Float %2.03%
Short Ratio0.45
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.19
P/FCF 32.1
P/OCF 16.48
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-3.13
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.06
FCFY3.12%
OCF(TTM)0.12
OCFY6.07%
SpS10.48
BVpS-1.65
TBVpS-1.7
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -107.17%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM 0.58%
ROA(3y)-21.86%
ROA(5y)-13.11%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover6.52
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 21.93
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.23
Quick Ratio 0.18
Altman-Z 1.26
F-Score4
WACC7.09%
ROIC/WACCN/A
Cap/Depr(3y)596.86%
Cap/Depr(5y)N/A
Cap/Sales(3y)4.21%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-145.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2053%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)84.68%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-145.39%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y715.78%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1299.37%
OCF growth 3YN/A
OCF growth 5YN/A

ABOVE FOOD INGREDIENTS INC / ABVE FAQ

What is the fundamental rating for ABVE stock?

ChartMill assigns a fundamental rating of 1 / 10 to ABVE.


What is the valuation status for ABVE stock?

ChartMill assigns a valuation rating of 1 / 10 to ABOVE FOOD INGREDIENTS INC (ABVE). This can be considered as Overvalued.


What is the profitability of ABVE stock?

ABOVE FOOD INGREDIENTS INC (ABVE) has a profitability rating of 0 / 10.


How financially healthy is ABOVE FOOD INGREDIENTS INC?

The financial health rating of ABOVE FOOD INGREDIENTS INC (ABVE) is 1 / 10.